{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:35:04Z","timestamp":1774265704632,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jash.2012.11.001","type":"journal-article","created":{"date-parts":[[2013,1,13]],"date-time":"2013-01-13T09:32:20Z","timestamp":1358069540000},"page":"46-60","source":"Crossref","is-referenced-by-count":45,"title":["Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients"],"prefix":"10.1016","volume":"7","author":[{"given":"Sumeet","family":"Panjabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2012.11.001_bib1","first-page":"61","article-title":"Vital signs: awareness and treatment of uncontrolled hypertension among adults - United States, 2003\u20132010","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jash.2012.11.001_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart Disease and Stroke Statistics\u20132011 Update: A report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2012.11.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/pop.2010.0019","article-title":"Quality of care associated with common chronic diseases in a 9-state Medicaid population utilizing claims data: an evaluation of medication and health care use and costs","volume":"14","author":"Priest","year":"2011","journal-title":"Popul Health Manage"},{"key":"10.1016\/j.jash.2012.11.001_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2012.11.001_bib5","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2012.11.001_bib6","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2012.11.001_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00149831-200506000-00010","article-title":"Adherence to antihypertensive treatment: a critical factor for blood pressure control","volume":"12","author":"Yiannakopoulou","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jash.2012.11.001_bib8","first-page":"999","article-title":"A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice","volume":"3","author":"Veronesi","year":"2007","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.jash.2012.11.001_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archinternmed.2007.72","article-title":"Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease","volume":"168","author":"Ho","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2012.11.001_bib10","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/01.hjh.0000187261.40190.2e","article-title":"Rate and determinants of 10-year persistence with antihypertensive drugs","volume":"23","author":"van Wijk","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2012.11.001_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1751-7176.2010.00360.x","article-title":"Rationale for triple-combination therapy for management of high blood pressure","volume":"12","author":"Gradman","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2012.11.001_bib12","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2012.11.001_bib13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archinte.165.10.1147","article-title":"Predictors of adherence with antihypertensive and lipid-lowering therapy","volume":"165","author":"Chapman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2012.11.001_bib14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.clinthera.2007.05.010","article-title":"Hypertension treatment in a Medicare population: adherence and systolic blood pressure control","volume":"29","author":"Fung","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jash.2012.11.001_bib15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.clinthera.2008.08.010","article-title":"Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database","volume":"30","author":"Jackson","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.jash.2012.11.001_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1751-7176.2009.00240.x","article-title":"High adherence to antihypertensive therapy is rare but when present is associated with a decreased risk of cardiovascular events","volume":"12","author":"Bloch","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jash.2012.11.001_bib17","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1185\/03007990802319364","article-title":"Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free- and fixed-dose combinations","volume":"24","author":"Brixner","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jash.2012.11.001_bib18","first-page":"652","article-title":"Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy","volume":"33","author":"Hess","year":"2008","journal-title":"P T"},{"key":"10.1016\/j.jash.2012.11.001_bib19","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1185\/03007995.2010.494462","article-title":"Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives","volume":"26","author":"Yang","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jash.2012.11.001_bib20","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1185\/03007995.2010.534129","article-title":"Adherence and persistence of single-pill ARB\/CCB combination therapy compared to multiple-pill ARB\/CCB regimens","volume":"26","author":"Zeng","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jash.2012.11.001_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1179\/175709208X334614","article-title":"Calculating medication compliance, adherence and persistence in administrative pharmacy claims databases","volume":"1","author":"Leslie","year":"2008","journal-title":"Pharmaceutical Program"},{"key":"10.1016\/j.jash.2012.11.001_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jash.2012.11.001_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2012.11.001_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MLR.0b013e3181d567bd","article-title":"Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs","volume":"48","author":"Dragomir","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.jash.2012.11.001_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00129784-200808010-00006","article-title":"Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine\/benazepril versus component-based free-combination therapy","volume":"8","author":"Dickson","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jash.2012.11.001_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"Sokol","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jash.2012.11.001_bib27","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","article-title":"Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients","volume":"120","author":"Mazzaglia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2012.11.001_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11606-009-1240-1","article-title":"Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death","volume":"25","author":"Bailey","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jash.2012.11.001_bib29","first-page":"568","article-title":"Antihypertensive medication adherence and subsequent healthcare utilization and costs","volume":"16","author":"Pittman","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jash.2012.11.001_bib30","first-page":"153","article-title":"Effects of nonadherence with prescription drugs among older adults","volume":"17","author":"Butler","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jash.2012.11.001_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3111\/13696998.2011.570401","article-title":"Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy","volume":"14","author":"Yang","year":"2011","journal-title":"J Med Econ"},{"key":"10.1016\/j.jash.2012.11.001_bib32","first-page":"2","article-title":"A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension","volume":"9","author":"Dezii","year":"2000","journal-title":"Manage Care"},{"key":"10.1016\/j.jash.2012.11.001_bib33","unstructured":"Panjabi SS, Swindle J, Buzinec P, Ramaswamy K, Wacha L. Adherence and medical cost patterns of treatment with RAS inhibitor\/amlodipine combinations [abstract]. Presented at: Annual Meeting & Expo of the Academy of Managed Care Pharmacy; San Francisco, CA; April 18\u201320,\u00a02012."}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171112002860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171112002860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T14:25:32Z","timestamp":1539959132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171112002860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1933171112002860"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2012.11.001","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}